Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Albany Street
Shapiro 9 Suite B
Boston, MA 02118Phone+1 617-414-4290Fax+1 617-414-4285
Summary
- I am a physician and scientist-entrepreneur currently working as a clinician in infectious diseases and as a consultant in global health. My background includes:
• >20 years experience in infectious diseases, travel medicine and international health
• >15 years experience in translational medicine, R&D financing, public-private partnerships, orphan diseases, and venture philanthropy
• Founder of innovative biotechnology and drug discovery companies
• Advisor to non-profit science organizations and life science start-ups
Education & Training
- Stanford University School of MedicineClass of 1983
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine
- Beth Israel Deaconess Medical CenterFellowship, Infectious Disease
- Wellcome Centre, Imperial College of Science and TechnologyPostdoctoral Fellow
- Ohio State UniversityB.A., Comparative Literature, with honors in the liberal arts
Certifications & Licensure
- MA State Medical License 1986 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- Royal College of Physicians, London, UKDiploma in Tropical Medicine and Hygiene
Publications & Presentations
PubMed
- 1728 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition)Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08
Journal Articles
- Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegansVed R, Saha S, Westlund B, et al, Journal of Biological Chemistry, 1/1/2005
- A reverse genetic analysis of components of the Toll signalling pathway in Caenorhabditis elegansPujol N, Link EM, Liu LX, et al, Current Biology, 1/1/2001
- Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor geneGil E, Malone EA, Liu LX, Johnson CD, Lees JA, Proc. National Academy of Sciences USA, 1/1/1999
- Join now to see all
Lectures
- Perspectives on the 2014-2015 Ebola outbreak in Sierra LeoneNational Academy of Medical Science, Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, N - 1/22/2016
- Things Fall Apart: Managing endemic infectious diseases in the wake of the Ebola outbreak in Port Loko District, Sierra Leone.Atlanta, GA - 1/25/2015
- Plagues and Peoples: The Origins and Spread of New Infectious DiseasesLawrence General Hospital - 1/28/2014
- Join now to see all
Press Mentions
- COVID-19 Has Caused A Shortage of Face Masks. But They're Surprisingly Hard to MakeMarch 16th, 2020
- ProMED Issues Ultimatum to Striking Moderators, as Questions About Site’s Future PersistAugust 30th, 2023
- Group Behind ProMED Fires Three Top Moderators Amid StrikeSeptember 9th, 2023
Grant Support
- 14 NIH and non-NIH (foundations, non-profits) grants totaling $6,282,265, as Chief Scientific OfficerNIH, Foundations2001–2010
- 11 NIH grants totaling $6,270,570 (direct costs), as Principal Investigator or Co-Principal InvestigatorNIH1990–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: